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Purpose. Limited data exists for the effects of sprint-interval training (SIT) and endurance training (ET) on total body composition,
abdominal visceral adipose tissue, and plasma inflammation. Moreover, whether “active” or “passive” recovery in SIT provides a
differential effect on thesemeasures remains uncertain.Methods. Sedentarymiddle-agedmen (𝑛 = 62; 49.5±5.8 y; 29.7±3.7 kg⋅m2)
underwent abdominal computed tomography, dual-energy X-ray absorptiometry, venepuncture, and exercise testing before and
after the interventions, which included the following: 12 wks 3 d⋅wk−1 ET (𝑛 = 15; 50–60min cycling; 80%HRmax), SIT (4–10 × 30 s
sprint efforts) with passive (P-SIT; 𝑛 = 15) or active recovery (A-SIT; 𝑛 = 15); or nonexercise control condition (CON; 𝑛 = 14).
Changes in cardiorespiratory fitness, whole-body and visceral fat mass, and plasma systemic inflammation were examined. Results.
Compared to CON, significant increases in interpolated power output (P-SIT, 𝑃 < 0.001; ET, 𝑃 = 0.012; A-SIT, 𝑃 = 0.041)
and test duration (P-SIT, 𝑃 = 0.001; ET, 𝑃 = 0.012; A-SIT, 𝑃 = 0.046) occurred after training. Final VO
2
consumption was
increased after P-SIT only (𝑃 < 0.001). Despite >90% exercise compliance, there was no change in whole-body or visceral fat
mass or plasma inflammation (𝑃 > 0.05). Conclusion. In sedentary middle-aged men, SIT was a time-effective alternative to ET
in facilitating conditioning responses yet was ineffective in altering body composition and plasma inflammation, and compared to
passive recovery, evidenced diminished conditioning responses when employing active recovery.
1. Introduction
Excessive abdominal visceral adipose tissue (VAT) quantity
and associated inflammatory cytokine secretion are linked to
the development of insulin resistance (IR) and type 2 diabetes
(T2D) mellitus [1, 2]. In turn, IR and T2D are precursors to
increased atherosclerotic disease progression and end-point
cardiovascular disease [3, 4]. Prevalence of obesity, metabolic
dysfunction, and consequent disease risk increases with age
[5]. Ageing is also associated with sedentary lifestyle and
physical inactivity, thus presenting a confluence of factors
for the development of whole-body and central obesity in
middle-aged populations [6]. A key perception cited for the
development of sedentary lifestyle is lack of time to engage
in (what is deemed to be) the appropriate volume of physical
activity [7].
Recent research indicates that sprint-interval training
(SIT) is a time-efficient modality that provides similar and/or
comparable health benefits to conventional endurance train-
ing (ET) [8–11]. SIT has been shown to increasemuscle oxida-
tive capacity [8, 9], cardiorespiratory fitness [10], endurance
performance [8–10], and importantly from a disease perspec-
tive, insulin sensitivity, and glucose metabolism [11]. It has
been suggested that, as is historically observed following ET,
SIT may also produce similarly commensurate reductions in
whole-body fat mass (FM) and VAT. Further, SIT may prove
to be a more time-effective alternative to ET given that most
middle-aged individuals do not meet recommended physical
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Table 1: Baseline subject characteristics.
Measure ET P-SIT A-SIT CON
Age (y) 51.1 ± 5.7 47.2 ± 5.1 49.1 ± 5.3 51.2 ± 7
Height (cm) 177.3 ± 4.4 177.9 ± 8.3 177.0 ± 8.9 176.5 ± 6.3
BMI (kg⋅m2) 30.6 ± 3.4 29.7 ± 4.1 29.7 ± 4.0 28.7 ± 3.6
Waist (cm) 104 ± 9 102 ± 11 100 ± 12 96 ± 9
WHR 1.00 ± 0.06 0.96 ± 0.05 0.97 ± 0.06 0.96 ± 0.06
Total chol. (mmol⋅L−1) 5.6 ± 1.3 5.6 ± 0.8 5.2 ± 1.2 5.8 ± 1.0
LDL chol. (mmol⋅L−1) 3.7 ± 1.2 3.7 ± 0.7 3.6 ± 0.9 3.8 ± 1.0
HDL chol. (mmol⋅L−1) 1.1 ± 0.2 1.1 ± 0.4 1.1 ± 0.3 1.2 ± 0.3
CHR 5.5 ± 1.6 5.7 ± 1.8 4.9 ± 1.5 5.1 ± 1.5
Triglycerides (mmol⋅L−1) 1.9 ± 1.1 1.8 ± 0.8 1.2 ± 0.7 1.7 ± 1.0
Glucose (mmol⋅L−1) 5.8 ± 0.4 5.7 ± 0.5 5.8 ± 0.6 5.4 ± 0.5
SBP (mmHg) 135 ± 12 131 ± 12 136 ± 13 138 ± 15
DBP (mmHg) 86 ± 10 81 ± 9 87 ± 10 92 ± 14
Data aremean± standard deviation. ET: endurance training condition (𝑛 = 15); P-SIT: passive sprint-interval training condition (𝑛 = 15); A-SIT: active sprint-
interval training condition (𝑛 = 15); CON: nonexercising control condition (𝑛 = 14). BMI: body mass index; WHR: waist to hip ratio; chol: cholesterol; LDL:
low-density lipoprotein; HDL: high-density lipoprotein; CHR: cholesterol hazard ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure. One-way
ANOVA comparisons showed no differences between conditions for baseline measures (𝑃 > 0.05).
activity guidelines [6, 12]; however, studies evidencing the
safety and outcome efficacy of SIT in middle-aged men are
emerging but remain limited.
While ET is largely a well-researched and accepted
modality for the reduction of whole-body FM and abdominal
VAT in multiple population groups [13, 14], limited evidence
exists to date as to whether SIT can produce similar results
to ET. There have been some recent studies which have
investigated the effect of interval-type training on central
obesity; however, the involved exercise was not maximal
(i.e., sprint-type) [15, 16], or there was no inclusion of
referencemethods to assess abdominal VAT such asmagnetic
resonance imaging or computed tomography [10, 16, 17].
Despite these shortcomings, in the studies of SIT, there were
decreases in measures of central obesity as well as whole-
body fat mass [10, 17]. Accordingly, there may be beneficial
effects of SIT on abdominalVAT reduction, yet, to the authors
knowledge, there has been no study to use reference method
VAT analysis of SIT, especially in comparison to conventional
ET.Moreover, the current SIT-central obesity data are limited
in application to middle-aged adults given that most data
pertains to younger trained/recreationally active participants
[10, 17]. In addition, some studies include only a SIT condition
(i.e., no ET or variation of SIT as a comparison) [10] or a cosex
design, thereby introducing potential sex-specific conflict in
pooled-sex analysis [10, 17]. Thus, further research is needed
in more appropriately examining the effects of SIT on whole-
body fat and abdominal VAT.
Importantly, abdominal VAT is a reported site for the
release of proinflammatory cytokines, which participate in
insulin signal transduction abnormalities and atheroscle-
rotic disease processes [1, 2, 5]. Of the previously studied
modalities, ET evidences the greatest capacity for abdominal
VAT reduction [13, 14]. That said, ET is the most exten-
sively studied modality, with minimal evidence thus far for
SIT. To date, ET appears to produce the most beneficial
response in, respectively, decreasing proinflammatory (e.g.,
tumor necrosis factor-𝛼 [TNF-𝛼], interleukin-6 [IL-6], and
C-reactive protein [CRP]) and increasing anti-inflammatory
cytokines (e.g., IL-4, and IL-10), collectively facilitating
cytokine profile (i.e., balance) towards a more normogly-
caemic/atheroprotective state [18–21]. Again, the effects of
SIT remain relatively unstudied and poorly understood. A
recent study concluded no effect of SIT on plasma systemic
inflammation, despite only incorporating a 2wk intervention
period [22]. Regardless of the lack of research for SIT, it
appears possible that if SIT elicits VAT reduction, decreases
may also be observed in plasma markers of chronic systemic
inflammation.
The purpose of this study was to compare 12 wks conven-
tional ET to SIT for effects on whole-body FM, abdominal
VAT, and systemic inflammation in sedentary middle-aged
men. A further aim was to examine whether additional
between-interval ET activity (i.e., passive versus active recov-
ery) would confer a different magnitude (i.e., greater extent)
of response on outcome data.We hypothesised that ETwould
decrease whole-body FM, abdominal VAT, and systemic
inflammation to a greater extent than the SIT conditions, with
active SIT being more effective than passive SIT.
2. Methods
2.1. Participants. Sixty-two middle-aged (40–60 y) men vol-
unteered for this study (data in Table 1). Participants were
sedentary at baseline, defined as no regular structured or
incidental exercise or physical activity >2 d⋅wk−1 in the 12
months priorly. Participants were screened by a physician
for preexisting diabetes, cardiovascular disease, renal or
hepatic disorders, immunological irregularities, rheumatoid
arthritis, periodontal disease, chronic obstructive pulmonary
disease, and any other condition linked to systemic inflam-
matory responses. Volunteers who were tobacco smokers
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(<1 y cessation), had orthopaedic limitations, or were taking
lipid-lowering, antihypertensive, anti-inflammatory, or other
potentially confounding medications were not involved in
the study. Following recruitment, participants attended an
information seminar and received written and verbal infor-
mation of all study procedures. Participants provided verbal
and written informed consent prior to becoming involved.
The study was approved by the Institutional Ethics committee
and conformed to standards for the use of human subjects
in research as outlined in 5th revision of the Declaration of
Helsinki.
2.2. Study Overview. After prescreening and recruitment,
eligible participants attended an information seminar where
all procedures were explained and discussed. In a fasted and
rested state, participants attended the Institutional Labora-
tory between 0530 and 0830 h for baseline testing and sequen-
tially completed computed tomography (CT), dual-energy
X-ray absorptiometry (DXA), blood pressure assessment,
anthropometry, venous blood collection, and a submaximal
exercise stress test (GXT). Participants were then randomized
into endurance (ET; 𝑛 = 15), “active” recovery sprint-interval
training (A-SIT; 𝑛 = 15), “passive” recovery sprint-interval
training (P-SIT; 𝑛 = 15), or a nonexercising control condition
(CON; 𝑛 = 14). Participants in the exercise groups completed
12wk, 3 d⋅wk−1 fully supervised, periodized, and progressive
programs. After the 12 wk intervention period and in a stan-
dardized manner (same time of day, same equipment, same
tester, etc.) according to pretesting, participants returned to
the laboratories and repeated all baseline test procedures.
Participants received no remuneration or incentives for their
involvement in the study.
2.3. Diet and Physical Activity Control. At the preinterven-
tion information and familiarisation seminar and regularly
throughout the interventions, all participants were briefed
verbally and in writing of the importance of maintaining
previous dietary and physical activity habits. Participants
were asked to maintain regular food and beverage type,
macronutrient content, cooking preparation, portion size,
consumption time, and so forth as closely as possible to
preintervention dietary patterns during the 12 wk study
period. Although sedentary at study baseline, participants
in the interventions were asked to maintain their prestudy
incidental physical activity habits and to not engage in any
additional planned or incidental physical activities during the
12 wk training period.
2.4. Graded Exercise Testing. Human ethics, Exercise and
Sports Science, Australia, and the American College of
Sports Medicine guidelines advocate the need for physician
supervision during maximal exercise testing as well as SIT in
the recruited cohort given age and risk-factor status. It was
not logistically possible to have a physician in attendance at all
exercise testing and training sessions.Thus, submaximalGXT
and SIT procedures were consequently administered with
85% of estimated heart rate (85% HRmax) maximum serving
as termination criteria in all study exercise procedures. Blood
pressure and electrocardiographic analysis were conducted
during the GXT for anomaly identification. Participants were
assessed (supervised by RR) for pressure and trace anoma-
lies associated with underlying disease (e.g., hypertensive
responses, ST-segment abnormalities, ectopic activity, and
bundle-branch blocks) likely to be exacerbated by exercise, as
previously recommended [23].One participantwas identified
as having concerning anomalies and was excluded; all others
were randomized to a study condition.
An electronically braked cycle ergometer (CASE ECG
Stress Test System, General Electric Medical Systems, Mil-
waukee, WI) was used to conduct the GXT. An initial power
output of 50W was followed by increments in power output
of 25W⋅min−1 until 85% of estimated heart rate maximum
(HRmax) was achieved, as identified via a cohort-specific
equation (205.9 − 0.685 × age) [24]. Expired gases and flow
volumes were collected during the GXT and analysed by
a calibrated metabolic cart (TrueOne 2400, ParvoMedics,
Salt Lake City, Utah) to provide oxygen uptake measures.
The GXT was terminated at the predetermined 85% HRmax
value. Interpolated 85% workload (last completed workload
+ fraction of last attemptedworkload) and test duration (time
to 85%) were recorded to provide intervention outcome data
and assist the respective training intervention programs.
2.5. Exercise Training Interventions. As exercise session dura-
tion is a primary consideration in time cost: benefit for
middle-aged cohorts, we opted to provide the advocated
guidelines as an upper limit for the ET methods (e.g., 150–
180min) and appropriately progressive SIT programs that
were matched to each other for session duration but consid-
erably shorter in duration (50%) than the ET condition. All
exercise sessions were directly administered and supervised
by the research team (JC and BC), with participant atten-
dance and compliance being documented and monitored
throughout. Training was standardized for time of day for
each participant and occurred within a climate-controlled
laboratory at the Institution. Heart rate, rating of perceived
exertion (RPE), cycling duration, pedalling resistance, inter-
val repetitions, and recovery time periods were all monitored
and controlled throughout the 12 wk intervention. All exer-
cise group participants received verbal familiarisation with
the exercise session structure, physiological demands, and
equipment used prior to commencing training and received
strong verbal encouragement throughout each session of the
program.
2.5.1. Endurance Training (ET). The ET program consisted
of cycle ergometry (828e, Monark AB, Varberg, Sweden) at
a workload which elicited ∼80–85% of age-predicted HRmax
or (initially) ∼90% of the final workload obtained in the
GXT. Training commenced at 50min⋅session−1 for Wks 1–6
and increased to 60min⋅session for Wks 7–12. Mean session
Watts, RPE, and heart rate were recorded in each session.
As participants conditioning increased, the workload was
increased so as tomaintain an intensity of∼80–85%ofHRmax.
2.5.2. Passive Recovery Sprint-Interval Training (P-SIT). The
P-SIT training program involved cycle ergometry (828E,
Monark Exercise AB, Varberg, Sweden) and included a 5min
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Table 2: Cardiorespiratory fitness measures.
Measure ET P-SIT A-SIT CON
Study compliance (%) 90.9 ± 7.3 91.2 ± 4.4 91.4 ± 7.6 —
Time GXT (s)
Pre 373 ± 98 380 ± 90 393 ± 87 389 ± 98
Post 446 ± 109∧ 470 ± 98∧ 455 ± 89∧ 400 ± 96
Raw Δ 73 ± 54∗ 90 ± 41∗ 62 ± 57 10 ± 49
% Δ 21 ± 17 25 ± 14 18 ± 17 3 ± 15
Peak output GXT (W)
Pre 180 ± 41 183 ± 38 189 ± 36 187 ± 41
Post 211 ± 46∧ 222 ± 38∧ 215 ± 36∧ 191 ± 40
Raw Δ 30 ± 23∗ 39 ± 18∗ 26 ± 24∗ 4 ± 20
% Δ 18 ± 14 23 ± 13 15 ± 14 3 ± 12
VO
2
GXT (L⋅min−1)
Pre 2.26 ± 0.46 2.33 ± 0.54 2.61 ± 0.47 2.33 ± 0.49
Post 2.60 ± 0.50 2.82 ± 0.55∧ 2.91 ± 0.53 2.41 ± 0.40
Raw Δ 0.34 ± 0.28 0.49 ± 0.22∗ 0.30 ± 0.29 0.07 ± 0.26
% Δ 16 ± 15 22 ± 12 12 ± 12 5 ± 13
VO
2
GXT (mL⋅kg−1⋅min−1)
Pre 23.6 ± 4.2 24.8 ± 4.8 28.2 ± 4.0 26.4 ± 6.0
Post 27.4 ± 5.2 29.9 ± 5.1∧ 31.3 ± 3.8 27.1 ± 4.9
Raw Δ 3.8 ± 3.3 5.1 ± 2.4∗ 3.1 ± 3.2 0.7 ± 3.3
% Δ 17 ± 16 22 ± 11 12 ± 12 4 ± 14
Data mean ± standard deviation. ET: endurance training condition (𝑛 = 15); P-SIT: passive sprint-interval training condition (𝑛 = 15); A-SIT: active sprint-
interval training condition (𝑛 = 15); CON: nonexercising control condition (𝑛 = 14). ∗Significant within-group change from baseline (𝑃 < 0.05). ∧Significant
between-group change (𝑃 < 0.05). GXT: graded exercise test at 85% of age-predicted heart rate maximum (HRmax); VO2: volume of oxygen uptake.
(limited) light-moderate warm-up/cool-down of either side
of a SIT component. The SIT component is comprised of
1 : 6 work : rest cycles, via 30 s sprint efforts followed by 3min
of passive recovery. Training commenced with four interval
efforts, increasing by one effort per fortnight, with 10 efforts
being completed at program completion. Pilot testing in an
analogous cohort revealed that a cadence of 120 rev⋅min−1
and 5-6% body mass resistance optimized the 30 s work
stimulus (e.g., required a “maximal” effort). In the between-
interval period, P-SIT participants either remained stationary
on the bike or were allowed restricted movement (slow walk-
ing; limited in distance) around the training room (60m2).
2.5.3. Active Recovery Sprint-Interval Training (A-SIT). The
A-SIT training program was identical in all program aspects
as the P-SIT program (same ergometers, number of efforts,
work cadence, progression, etc.); however, it consisted of
3min (between-interval) periods involving continued cycling
at 60 rev⋅min−1 at a lightened resistance (e.g., 1.0–1.5 kp,
depending on the participant). Pilot testing confirmed that
this combination of cadence and resistance permitted suffi-
cient recovery so as to ensure that participantswere to achieve
120 rpm for similar time duration as P-SIT participants
during each ensuing interval effort.
2.6. Measures
2.6.1. Computed Tomography. At baseline testing, partici-
pants firstly arrived at a local radiology facility for computed
tomography of the abdominal region. Upon arrival, partic-
ipants voided the bladder and were positioned as central
as possible in the gantry regarding vertex-pubis symphysis
alignment. An anterior-posterior scanogram (scout radio-
graph) of the lower abdomen and pelvis was conducted using
a 64-slice multidetector CT (Toshiba Aquilion, ToshibaMed-
ical Systems, Tokyo, Japan). A volume acquisition compart-
ment 77mm in length was obtained (120 kv, 50mA, and 0.5 s
tube rotation) cephalically from the superior end-plate of L4
during suspended inspiration. After scanning, eleven 7.0mm
contiguous axial images were reconstructed in a maximal
display field of view (500mm) for volume calculation with
an attenuation range of −180 to −30 Hounsfield units, and the
total adipose tissue (TAT), VAT and subcutaneous adipose
tissue (SAT) compartments were determined as described
previously [25].
2.6.2. Dual-Energy X-Ray Absorptiometry, Anthropometry
and Blood Pressure Assessment. A supine DXA scan was
undertaken to estimate whole-body composition (Norland
XR800, Cooper Surgical Company, Turnbull, CT, USA). Par-
ticipants were positioned centrally on the bench of the DXA
machine and a whole-body scan was completed with a reso-
lution of 4.5 × 9.0mm and scanning speed of 130mm⋅sec−1.
The scan was then analysed with customized software (Illu-
minatus DXA, version 4.2.0, Turnbull, CT, USA) for FM and
fat free mass (FFM) which are reported in absolute (kg) and
relative (%) terms. All pre- and postintervention scanning
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Table 3: Body mass and composition data.
Measure ET P-SIT A-SIT CON
Body mass (kg)
Pre 96.2 ± 11.4 94.8 ± 20.2 93.9 ± 18.9 89.4 ± 12.1
Post 95.7 ± 12.4 95.7 ± 21.2 94.1 ± 19.1 89.8 ± 12.2
Raw Δ −0.5 ± 3.5 0.8 ± 1.6 0.2 ± 1.2 0.5 ± 1.2
% Δ −0.6 ± 3.9 0.7 ± 1.6 0.2 ± 1.4 0.5 ± 1.4
FFM (kg)
Pre 70.8 ± 7.5 71.4 ± 10.7 70.9 ± 11.6 67.7 ± 6.6
Post 71.2 ± 7.8 72.8 ± 11.2 71.9 ± 11.6 69.2 ± 6.7
Raw Δ 0.37 ± 1.5 1.5 ± 1.9 1.0 ± 1.6 1.4 ± 1.0
% Δ 0.5 ± 2.2 2.0 ± 2.4 1.4 ± 2.2 2.1 ± 1.3
FM (kg)
Pre 27.2 ± 8.7 24.8 ± 10.9 24.4 ± 8.7 23.3 ± 7.6
Post 28.2 ± 9.6 25.2 ± 11.8 25.1 ± 9.4 23.5 ± 7.1
Raw Δ 1.0 ± 2.1 0.4 ± 2.0 0.7 ± 1.7 0.2 ± 1.3
% Δ 3.5 ± 9.1 1.3 ± 8.5 2.7 ± 6.5 1.8 ± 7.4
FM (%)
Pre 27.3 ± 6.5 25.0 ± 5.8 25.0 ± 5.3 25.1 ± 5.4
Post 27.9 ± 7.0 24.8 ± 6.0 25.2 ± 5.4 24.9 ± 4.6
Raw Δ 0.6 ± 1.6 −0.2 ± 1.7 0.2 ± 1.4 −0.2 ± 1.2
% Δ 1.9 ± 6.5 −0.5 ± 7.8 1.0 ± 5.7 0.0 ± 6.4
SAT (cm3)
Pre 2396 ± 843 1952 ± 773 2153 ± 788 1852 ± 719
Post 2415 ± 918 1924 ± 746 2179 ± 873 1886 ± 660
Raw Δ 19 ± 163 −29 ± 113 26 ± 188 34 ± 161
% Δ 0.1 ± 7.5 −1.3 ± 6.3 0.7 ± 7.2 4.2 ± 12.2
VAT (cm3)
Pre 1474 ± 427 1540 ± 596 1353 ± 568 1225 ± 448
Post 1489 ± 447 1482 ± 588 1331 ± 705 1441 ± 569
Raw Δ 16 ± 338 −58 ± 302 −22 ± 367 216 ± 280
% Δ 3.2 ± 23.6 −3.0 ± 14.8 −1.3 ± 20.2 18.4 ± 22.5
TAT (cm3)
Pre 3870 ± 1031 3492 ± 1162 3506 ± 1253 3077 ± 1038
Post 3904 ± 1210 3405 ± 1246 3510 ± 1453 3327 ± 1095
Raw Δ 35 ± 427 −87 ± 238 4 ± 452 250 ± 294
% Δ 0.4 ± 11.8 −3.0 ± 5.8 −0.3 ± 9.7 8.8 ± 10.7
VAT (%)
Pre 38.8 ± 8.5 44.0 ± 8.4 37.8 ± 7.9 40.3 ± 8.4
Post 38.8 ± 7.4 43.3 ± 6.4 37.0 ± 8.6 43.0 ± 7.6
Raw Δ 0.1 ± 4.8 −0.7 ± 4.8 −0.8 ± 4.5 2.7 ± 5.5
% Δ 1.7 ± 12.8 −0.4 ± 10.6 −1.8 ± 12.2 8.2 ± 13.7
Data are mean ± standard deviation. ET: endurance training exercise group,
𝑛 = 15; P-SIT: passive sprint-interval training exercise group, 𝑛 = 15; A-
SIT: active sprint-interval training exercise group, 𝑛 = 15; CON: control
group, 𝑛 = 14. FFM: total body fat free mass; FM: total body fat mass;
SAT: subcutaneous adipose tissue; VAT: abdominal visceral adipose tissue;
TAT: total abdominal adipose tissue.There were no significant pre-to-post or
between-condition differences in body compositionmeasures after the study
interventions (𝑃 > 0.05).
procedures and analyses were standardized pre to post (e.g.,
fasted, rested, no alcohol in the prior 24 h, scan settings, and
participant positioning).
Table 4: Measures of plasma systemic inflammation.
Measure ET P-SIT A-SIT CON
CRP (mg⋅L−1)
Pre 2.8 ± 1.6 2.7 ± 1.3 2.1 ± 1.4 2.1 ± 1.5
Post 2.9 ± 1.6 2.1 ± 0.9 1.9 ± 1.2 2.1 ± 1.6
Raw Δ 0.2 ± 1.2 −0.6 ± 1.0 −0.2 ± 0.9 0.0 ± 0.9
% Δ 11.8 ± 40.9 −12.3 ± 50.7 −1.5 ± 34.6 24.3 ± 118.5
IL-6 (pg⋅L−1)
Pre 3.16 ± 1.36 3.11 ± 1.04 3.29 ± 0.53 3.27 ± 0.64
Post 3.55 ± 0.75 3.18 ± 0.63 3.57 ± 0.38 3.65 ± 0.81
Raw Δ 0.40 ± 1.03 0.08 ± 1.01 0.28 ± 0.46 0.37 ± 0.77
% Δ 22.8 ± 30.6 10.9 ± 35.5 10.1 ± 14.0 12.9 ± 23.2
TNF-𝛼 (pg⋅L−1)
Pre 6.1 ± 1.7 6.8 ± 1.5 6.6 ± 1.8 5.2 ± 1.4
Post 6.8 ± 2.1 6.6 ± 1.9 6.4 ± 1.9 5.7 ± 1.3
Raw Δ 0.7 ± 1.6 −0.2 ± 2.2 −0.2 ± 1.3 0.5 ± 1.5
% Δ 13.7 ± 28.8 1.3 ± 31.9 −1.6 ± 23.1 16.0 ± 33.5
MCP-1 (pg⋅L−1)
Pre 121 ± 43 137 ± 43 145 ± 46 111 ± 86
Post 121 ± 38 129 ± 33 141 ± 43.02 109 ± 84
Raw Δ −0.2 ± 33.0 −7.5 ± 43.3 −4.1 ± 34.1 −1.8 ± 61.6
% Δ 7.7 ± 37.9 4.0 ± 41.0 3.1 ± 28.8 25.8 ± 92.2
IL-10 (pg⋅L−1)
Pre 3.72 ± 2.78 3.77 ± 3.03 3.32 ± 2.32 4.98 ± 2.40
Post 5.31 ± 5.25 5.77 ± 4.59 2.93 ± 1.47 5.35 ± 3.17
Raw Δ 1.59 ± 3.72 2.00 ± 4.08 −0.39 ± 2.00 0.38 ± 1.97
% Δ 53.2 ± 85.2 118.0 ± 218.3 16.7 ± 84.5 8.8 ± 42.6
Data are mean ± standard deviation. ET: endurance training exercise group,
𝑛 = 15; P-SIT: passive sprint-interval training exercise group, 𝑛 = 15; A-SIT:
active sprint-interval training exercise group, 𝑛 = 15; CON: control group,
𝑛 = 14. CRP: C-reactive protein; IL-6: interleukin 6; TNF𝛼: tumor necrosis
factor 𝛼; MCP-1: monocyte chemoattractant protein 1; IL-10: interleukin 10.
There were no significant pre-to-post or between-condition differences in
plasma CRP and cytokine measures after the study interventions (𝑃 > 0.05).
Following DXA, measurements of body mass and waist
and hip circumference were obtained for each participant.
Body mass was taken wearing minimal clothing and stan-
dardized before and after intervention.Waist and hip circum-
ference measurements were collected as described previously
[26] and by the same tester before/after intervention (CD).
Blood pressure was measured via auscultation after ∼10min
of rest. Systolic and diastolic pressures were recorded three
times with a 1min rest period between measurements. The
lowest paired systolic and diastolic values were recorded.
2.6.3. Venous Blood Collection and Analysis. Participants
then underwent venepuncture procedures inwhich a cannula
was inserted into a medial antecubital vein and blood was
manually drawn by syringe and gently ejected into prechilled
(on ice) tubes treated with ethylenediaminetetraacetic acid
and serine protease inhibitor (Pefabloc SC, Sigma-Aldrich,
Sydney, Australia) to prevent cytokine degradation. Drawn
blood was also ejected into serum separator tubes and left
to clot within ∼20–30min. The prechilled and clotted serum
tubes were centrifuged (refrigerated) for 10min at 4∘C, and
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plasma and serum specimens were stored at −80∘C until
analysis (<2wks after collection).
Serum was analysed for total cholesterol, high-density
lipoprotein cholesterol, triglycerides, glucose, and CRP on
a high-throughput automated blood analyser according to
the manufacturer and respective kit instructions (Dimension
EXL, Siemens Healthcare Diagnostics, Sydney, Australia).
The Friedewald equation was used to estimate low-density
lipoprotein cholesterol as described previously [26]. Intra-
and interassay coefficient of variation (CV) were less than
6.1% for all measured analytes. Commercially available
enzyme-linked immunosorbent assays (Jomar Life Research,
Melbourne)were used to analyse plasma for IL-6, IL-10, TNF-
𝛼, and MCP-1. Each participant pre- and postsample was
loaded sequentially on the same plate, and all standard curves
were 𝑅 ≥ 0.99. Intra- and interassay CV were reported
(manufacturer) <10% for all analytes.
2.7. Statistical Analysis. A sample size of ≥10 participants
per condition was required in order to acquire an effect
size of 0.25 at 𝛼 = 0.05 according to a priori analysis [27]
(G∗Power v.3). However, >14 participants were involved to
help avoid type II error. The subject sample size used in
this study is similar to recent studies which have reported
significant intervention effects of ET and SIT on measures of
body composition [10, 16, 17]. Repeated-measures analysis of
covariance (ANCOVA) was used to assess condition × time
interactions with baseline data (for each respective variable)
used as the covariate. If a main effect was observed in
the ANCOVA, one-way ANOVA with Bonferroni’s multiple
comparison post hoc tests applied to determine significant
differences. Effect size (ES) data for pre-to-post change and
between-group differences were determined using unbiased
Hedges Cohen’s𝑑 calculation (trivial:<0.20; small: 0.20–0.49;
moderate: 0.50–0.79; or large: >0.80). Statistical significance
for the ANCOVA and one-way ANOVA was accepted when
𝑃 < 0.05. ES data was only reported if deemed to have
an upper moderate or large effect (𝑑 > 0.70). All data are
presented as mean ± standard deviation (SD).
3. Results
3.1. Exercise Training Compliance. All subjects attended >30
of the 36 organised exercise training sessions (∼91%), with
mean session attendance being 32 of the 36 sessions (see
Table 2). One-way ANOVA revealed that there was no
significant difference in training compliance between groups
(𝑃 > 0.05). While there were no adverse events arising
from the exercise training interventions, 3 participants, one
from each of the P-SIT, A-SIT, and CON groups, respectively,
did not complete the 12 wk interventions (1n = orthopaedic
limitations; 2n = time constraints) and were excluded from
analysis, resulting in final numbers: ET (𝑛 = 15), P-SIT (𝑛 =
15), A-SIT (𝑛 = 15), and CON (𝑛 = 14).
3.2. Cardiorespiratory Fitness Measures. A significant main
effect was identified for increases in VO
2
uptake, power
output, and GXT time duration at 85% HRmax (𝑃 < 0.05).
One-wayANOVA identified increases for peak output (P-SIT,
𝑃 < 0.001; ET, 𝑃 = 0.009; A-SIT, 𝑃 = 0.05), time duration
(P-SIT, 𝑃 = 0.001; ET, 𝑃 = 0.01), and VO
2
at 85% HRmax
(L⋅min−1) (P-SIT, 𝑃 = 0.001) (Table 2). In comparison
to CON, at 85% HRmax, there was a significant pre-to-post
difference by the exercise interventions for increases in power
output (P-SIT, 𝑃 < 0.001; ET, 𝑃 = 0.012; A-SIT, 𝑃 =
0.041), time duration (P-SIT, 𝑃 = 0.001; ET, 𝑃 = 0.012;
A-SIT, 𝑃 = 0.046), and VO
2
(L⋅min−1) (P-SIT, 𝑃 < 0.001)
(Table 2). Although no significant differences in change of
VO
2
at 85% HRmax (L⋅min
−1) were observed between the
CON and ET (𝑃 = 0.063) or CON and A-SIT (𝑃 = 0.055),
between-group ES data showed a trend for difference (ET
versus CON, 𝑑 = 0.97; A-SIT versus CON, 𝑑 = 0.81).
3.3. Body Composition, Abdominal CT, and Anthropometry.
There was no significant difference in anthropometry mea-
sures after the interventions (𝑃 > 0.05) and only trivial
to moderate ES data for pre-to-post and between-condition
comparisons (all 𝑑 < 0.60). Further, there were no significant
changes in FM, FFM, or abdominal CTmeasures pre-to-post
or between conditions (𝑃 > 0.05) (see Table 3). The ES data
indicated only trivial to small (all 𝑑 < 0.22) ES data for
changes in FM and FFM. Although a large effect between
CON-ET groups presented for FFM increase (𝑑 = 1.36),
ES data for pre-to-post change in abdominal CT were small
to trivial (all 𝑑 < 0.41). However, for VAT (cm3), a large
and moderate ES, respectively, presented between P-SIT and
CON (𝑑 = 0.91) and A-SIT and CON (𝑑 = 0.70). For
VAT (%), a moderate ES presented between A-SIT and CON
(𝑑 = 0.78) and P-SIT and CON (𝑑 = 0.78).
3.4. Biochemistry, Plasma CRP, and Cytokines. There were
no significant pre-to-post or between-condition differences
of fasting glucose, cholesterol, LDL, HDL or triglycerides
(𝑃 > 0.05). Aside from moderate ES data for a pre-to-post
difference in glucose between CON and A-SIT (𝑑 = 0.77), all
pre-to-post (all 𝑑 < 0.57) and between-group (all 𝑑 < 0.58)
biochemistry ES data were trivial to moderate.There were no
significant pre-to-post or between-condition differences for
plasma CRP or studied cytokines (𝑃 > 0.05; see Table 4). The
ES data showed a moderate ES for CRP reduction between
P-SIT and ET (𝑑 = 0.70) and for IL-10 moderate ES for
increase between P-SIT and A-SIT (𝑑 = 0.71). Otherwise,
only trivial to moderate ES data were detected for pre-to-post
(all 𝑑 < 0.59) and between-group (all 𝑑 < 0.65) changes of
CRP and the studied cytokines.
4. Discussion
This study compared conventional ET to age/health-status
appropriate SIT for respective effects on whole-body com-
position, abdominal VAT, and pro- and anti-inflammatory
cytokine concentrations in a sedentary overweight middle-
aged male population. This study also examined whether a
passive (P-SIT) or active (A-SIT) recovery period (between-
intervals efforts) would facilitate a differential magnitude of
response in outcome measures. Specifically, in addition to
completing the P-SIT program, the A-SIT group completed
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further 27–81mins (range fromWks 1–12) of moderate inten-
sity exercise per week. We incorporated this study design
to ascertain whether the coupling of ET with P-SIT (in
recovery) offered additive effects to outcome measures. After
intervention, we observed significant improvements in fitness
measures across all exercise conditions, yet, surprisingly,
increases observed in P-SIT appeared more robust in com-
parison to A-SIT, despite matching of the 30 s interval efforts.
Accordingly, while requiring further elucidation, in the stud-
ied population, there may be evidence of an inhibitory effect
of combining ET with SIT, exacerbated via the absence of
sufficient between-effort “recovery” periods. Previously, ET
and SIT have both been reported to significantly reduce body
fat [10, 16, 17]; however, to date, of ET and SIT, only evidence
exists for a positive effect of ET on abdominal VAT [13]. In
the studied cohort, our 12 wk intervention did not result in a
reduction of FM or abdominal VAT following either of the
SIT interventions. In addition, we observed no changes in
inflammatory measures following all exercise interventions.
Such a response raises further questions regarding the efficacy
of exercise training without caloric restriction to facilitate
favourable changes in body composition, abdominal VAT,
and chronic systemic inflammation.
Accumulating evidence supports that SIT is a time-
efficient alternative to conventional ET for the facilitation
of musculoskeletal adaptations associated with oxidative
metabolism [8–11]. In this study, all three exercise conditions
improved measures of cardiorespiratory fitness; however,
P-SIT appeared to elicit the greatest relative changes and
difference to the CON across each cardiorespiratory fitness
measure. These data further support the work of these previ-
ous studies and further highlight the role of exercise intensity
(compared with duration) in eliciting rapid exercise-induced
conditioning-based adaptations. However, the blunted car-
diorespiratory fitness improvements observed in A-SIT
(when compared to P-SIT) indicate that an inhibitory effect
may be present in the A-SIT data. Nader [28] has previously
outlined the concurrent training “effect,” wherein the combi-
nation of strength and endurance exercise results in potential
molecular interference in phenotype-specific adaptive sig-
nalling and diminished adaptation in comparison to single-
mode completion (e.g., strength or endurance alone). The A-
SIT sessions here could be viewed as inducing short-duration
high-intensity periods ofmaximal forcewith similar duration
to 8–10 RM strength-training set, yet combined with contin-
uous moderate intensity endurance exercise in the recovery
period.Thus, the A-SIT condition essentially parallels aspects
of “Fartlek-”style training, which is ingrained in training
programs of many well-conditioned/prepared athletes [29,
30]. Nevertheless, in the studied population group, there may
have been a detrimental effect given their lack of condition
to accommodate the intense training stimulus. As reported
previously, potential inhibitory mechanisms observed as a
result of a concurrent training effect include diminished neu-
ral activation rapidity, impaired glycogen regulation, muscle
fiber-type transformation, ADP-ATP ratio, and associated
effect onmolecular signalling processes orchestrating muscle
protein turnover [28]. Further research may be warranted
in investigating these mechanisms in response to A-SIT
(compared to P-SIT) in deconditioned middle-aged popula-
tions.
Contrary to the findings in this study, SIT and ET have
previously been shown to decrease body mass and whole-
body FM, thereby positively influencing relative whole-
body composition [10, 16, 17]. Accumulating data indicates
that 150min⋅wk−1 of moderate intensity exercise may be
insufficient to reduce body mass and may only serve to
maintain or ameliorate gain in weight [12, 31]. In our
study, the ET group commenced at 150 and progressed to
180min⋅wk−1 and cycled at a moderate-to-vigorous intensity.
The data shows lack of change in whole-body FM and raises
questions as to whether middle-aged populations should
be increasing session and thus total weekly duration or
focusing on optimization of intensity. Accordingly, we sought
to appraise an appropriate SIT intervention as an alternative
to ET, and, like ET, we observed a limited effect of SIT
on whole-body FM. Keating et al. [16] recently reported
that moderate intensity cycling ∼108–144min⋅wk−1 over a
12 wk intervention elicited significant reductions in whole-
body FM; however, a SIT condition in this study did not
alter whole-body or trunk FM. In contrast, prior research
has demonstrated that SIT can be effective in reducing
whole-body FM [10, 17].These reductions observed generally
appear to be comparable to reductions after ET, yet, in
some studies, SIT is reportedly more effective than ET in
decreasingwhole-body FM [10, 17]. As evidence,Macpherson
et al. observed that a SIT protocol of 4–6 repetitions of 30 s
maximal running efforts 3 sessions⋅wk−1 for 6 weeks elicited
a 12.4% decrease in FM opposed to a 5.8% decrease in a
ET group (program range: 90–180min⋅wk−1). However, this
study investigated recreationally activemen andwomen (24 y
mean age) and thus whether these age-based and sex-pooled
findings apply to overweight middle-aged men remains
uncertain. Although data support suggests that SIT may be
as effective as ET as a regular exercise alternative [8–11], no
current physical guidelines for SIT have been implemented
and its effect on health-related outcomes such as whole-body
FM are thus far inconsistent and require further elucida-
tion.
Mounting evidence substantiates that the extent (quan-
tity) and dysfunctional regulation (atherogenicity) of abdom-
inal VAT are associated with the extent and progression of
metabolic and cardiovascular disease [5, 25]. These findings
support why the reduction of VAT currently occupies a
central focus in the prevention of these diseases [32]. In this
study, there were no differences observed in abdominal VAT
in response to the ET or SIT exercise interventions. Histori-
cally, ET appears to be themost effective exercisemodality for
the reduction of abdominal VAT, as shown by a recent meta-
analysis and systematic review [13]. Currently, data for the
effect of SIT onVAT remain sparse, especially in combination
with whole-body FM data. However, similar to our study,
others have also reported no effect of SIT on trunk fat (via
DXA) [17]. While data are lacking for the effects of SIT on
abdominal VAT (CT/MRI-derived) and/or trunk fat (DXA-
derived), some interval-type exercise research has reported
decreases in measures of central obesity [33, 34]. Hottenrott
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et al. [33] observed that a high-intensity running-based
SIT program (4 × 30min sessions with 30–120 s intervals)
resulted in significant decreases in abdominal VAT; however,
these authors used bioelectrical impedance for assessment
of abdominal VAT rather than CT or MRI. Furthermore,
although theoretically matched for training duration to an
ET condition, the SIT condition included greater training
frequency and a substantial incorporation of ET, thus raising
questions as to whether it was the isolated effect of SIT
per se. In using similar exercise methodology to our study,
Trapp et al. [34] observed a significant reduction in trunk fat
mass following a 20min 3 d⋅wk−1 high-intensity intermittent
sprint condition (cycles of 8 s sprint: 12 s recovery).While our
interventions found no pre-to-post differences for abdominal
VAT, the CON group marginally increased visceral FM. As
such, it appears that ET and SIT may have potentially offset
gain in VAT across the intervention period, siding with prior
research that exercise may serve as a preventative tool against
increases in VAT [35].
Equivocal and inconsistent evidence precludes current
understanding of the capacity for exercise to decrease mark-
ers of chronic systemic inflammation. Some studies report no
change in CRP or inflammatory cytokines following exercise
intervention [20, 21, 26, 36, 37], while other studies report
significant reductions [18–21, 38, 39]. Despite conflicting
data to date, in studies where plasma concentrations of
CRP and cytokine concentrations reductions are observed,
ET appears the more effective modality [18, 19, 21, 39, 40].
The effects of SIT on positively influencing cytokine profile
(reducing proinflammatory; increasing anti-inflammatory)
are still uncertain. Leggate et al. [22] examined the effect
of a 2wk SIT intervention on inflammation and reported
no change in TNF-𝛼, IL-6, MCP-1, or IL-10, suggesting
that SIT may be relatively ineffective in changing cytokine
profile. The limited duration of their intervention would
likely have promoted limited/no change in VAT and (the-
oretically) associated inflammation, which appears to be a
consistent finding in other studies [1, 2, 5]. We opted to
investigate a longer duration SIT intervention period in
order to increase the likelihood of a reduction in VAT and
thus associated proinflammatory cytokines (TNF-𝛼, IL-6,
CRP, and MCP-1). The lack of change in these measures
may be explained by the lack of change in abdominal
VAT. Further research is needed to verify whether exercise-
induced reduction of VAT is essential for reduction of these
markers, as our data are inconclusive to show such an
effect.
In addition, we examined whether SIT (or ET) may
have imparted an anti-inflammatory effect, as would be
indicated via increased IL-10 concentrations after training
[18, 20, 21, 40]. Despite no significant change denoted in
IL-10 for this study, both P-SIT and ET exercise groups
evidenced a trend for an increase. However, a large SD, due to
large interindividual response variance may have precluded
significance. Despite power analyses indicating 𝑛 of 15 per
group sufficient to yield statistical significance, and that
recent studies have incorporated a similar [16] or smaller
[10] sample sizes as this study, a larger sample size in our
study may have further substantiated a limited effect of the
exercise interventions. In addition, there is existing evidence
that 12 wksmay induce adaptations which are associated with
enhanced metabolic and/or immune regulatory function,
yet subsequent effects of these adaptations are not observed
until ensuing periods (i.e., at 6 or 12 months). Thus, a
limitation of the current study may also be that a longer
time frame is required to impart a significant effect on body
composition and related plasma inflammatory measures.
An additional limitation to our study is that it cannot
be ruled out that changes in habitual diet and physical
activity may have influenced the study data. In this view,
while we strongly emphasised the maintenance of diet and
planned/incidental physical activity across the 12 wk period,
it is possible that that there may have been some alteration
in satiety (in response to the exercise) and/or a decrease in
incidental activity given potential training-induced weari-
ness/fatigue from the conducted exercise training ses-
sions.
In undertaking SIT, participants are required to com-
plete supramaximal sprint efforts which are metabolically
anaerobic in nature and physically demanding given the
involved intensity. Even though, SIT was well-tolerated in
this study by all participants, with optimal study compliance
and very low study attrition. Accordingly, this method of
exercise may be favourable for adoption in the general
public, obviously after thorough preexercise medical health
screening. Nevertheless, further research is needed to iden-
tify a more appropriate means of monitoring the interplay
between exercise intensity and cardiovascular work given
that, in SIT exercise, participants are undertaking exercise
with maximal exertion, yet with delay in the heart rate
response. Accordingly, relative submaximal HRmax criteria
arguably appear redundant given our observation that most
participants did not breach 85% HRmax until the conclusion
of or immediately after interval.
In conclusion, 12 wks of ET, P-SIT, or A-SIT in an over-
weight middle-aged male population appeared ineffective
in altering whole-body FM, abdominal VAT, or plasma
markers underlying chronic systemic inflammation.The lack
of change in body composition and abdominal VAT may
underline the lack of change in the inflammatory markers.
Aligning with previous research, this study has shown P-SIT
to promote comparable cardiorespiratory fitness improve-
ments to that of ET. However, it is worth emphasising that
the present fitness improvements were based on the use
of participant’s baseline data with VO
2peak as the covariate.
However, given that the A-SIT condition presented evidence
of a diminished conditioning response in comparison to
P-SIT, questions are raised regarding the use of “active”
recovery periods in SIT programs involving deconditioned
cohorts. Further research may be warranted in examining
whether inhibitory mechanisms may be involved in A-
SIT versus P-SIT in initially sedentary or deconditioned
adults.
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